Jerome is Chief Scientific Officer and Co-founder of Callio Therapeutics where he oversees research and early development. Prior to co-founding Callio Therapeutics, Jerome co-founded Hummingbird Bioscience. Jerome’s career has focused on tackling human disease by applying systems biology approaches. A molecular biologist by background with extensive experience in computational and wet lab biology, Jerome holds a Bachelor’s and Master’s degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.